Volume 13, Number 1—January 2007
Research
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*
Table 4
Multivariable analysis of discordant versus concordant empiric antimicrobial drug therapy in patients with multidrug-resistant Acinetobacter infections, Baltimore hospitals, 2003–2004*
| Outcome evaluated | Discordant vs. concordant empiric antimicrobial drug therapy† | |
|---|---|---|
| OR (95% CI) | p value | |
| Length of stay, d | 1.6 (0.4–6.5) | 0.54 |
| Intensive care unit length of stay, d | 5.8 (1.2–27.1) | 0.03 |
| Mortality rate (%) | 0.7 (0.1–4.5) | 0.74 |
*OR, odds ratio; CI, confidence interval.
†Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.
